
Immunotherapy for acute myeloid leukemia (AML): a potent alternative therapy
Keywords: AML; acute myeloid leukemia; GO; gemtuzumab ozogamacin; PBD; pyrrolobenzodiazepine; HuM196; humanized murine 196; CARs; chimeric antigen receptors; LAA; leukemia associated antigens; TCRT; cell receptor; NKG2D; natural killer group 2 D; MHC; major histoco